Islet amyloid and type 2 diabetes mellitus;Eilandjesamyloid en diabetes mellitus type 2

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 42, 2000, Pages 1995-2000

  Hoppener, J W M ^a   Nieuwenhuis, M G ^a   Vroom, Th M ^a   Lips, C J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; INSULIN;

AMINO ACID SEQUENCE; CELL DEATH; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; INSULIN SYNTHESIS; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; SYMPTOM; AMYLOIDOSIS; ANIMAL; GENETICS; INSULIN RESISTANCE; METABOLISM; MOLECULAR GENETICS; MOUSE; PANCREAS DISEASE; PANCREAS ISLET; PATHOLOGY; SECRETION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PANCREATIC DISEASES;

EID: 0034649088     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans
2. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas
3. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells
4. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle
5. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes
6. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population
7. IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion
8. Islet amyloid polypeptide: Identification and chromosomal localization of the human gene
9. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice
10. The complete islet amyloid polypeptide precursor is encoded by two exons
11. Islet amyloid polypeptide (amylin): No evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients
12. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation
13. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice
14. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)
15. IAPP/amylin gene transcriptional control region: Evidence for negative regulation
16. The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes
17. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients
18. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus
19. Amyloidosis: A review of recent diagnostic and therapeutic developments
20. Amyloid P component. A critical review
21. Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes
22. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects
23. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance
24. Pancreatic islet amyloid formation in patients with non-insulin-dependent diabetes mellitus. Implication for therapeutic strategy
25. Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia
26. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model
27. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide
28. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
29. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
30. Islet amyloid and type 2 diabetes mellitus
31. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles
32. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice
33. Ten-year follow-up of subjects with impaired glucose tolerance: Prevention of diabetes by tolbutamide and diet regulation